###begin article-title 0
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 229 235 229 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 493 499 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
Acute anterior uveitis (AAU) is the most common form of uveitis and is thought to be autoimmune in nature. Recent studies have described genes that act as master controllers of autoimmunity. Protein tyrosine phosphatase type 22 (PTPN22) and Cytotoxic T lymphocyte antigen-4 (CTLA-4) are two of these genes, and single nucleotide polymorphisms (SNPs) in the genes encoding these molecules have been associated with several autoimmune diseases. In this study we have analyzed SNPs in PTPN22 and CTLA-4 in patients with AAU.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 281 282 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
The functional protein tyrosine phosphatase type 22 (PTPN22) SNP (R620W , 1858C/T), and two CTLA-4 SNPs (, -318C/T and , 49A/G) were analyzed in 140 patients with AAU and 92 healthy controls by sequence-specific primer -polymerase chain reaction (SSP-PCR). Data was analyzed by chi2 analysis and Fisher's exact test.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 289 296 <span type="species:ncbi:9606">patient</span>
There was no significant association between PTPN22 620W, CTLA-4 -318C/T, or CTLA-4 49A/G and AAU. Similarly, there was no association with the three SNPs when patients were classified by race or gender. Finally, there was no association with the presence of ankylosing spondylitis in the patient cohort.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
The data do not support an association between SNPs in PTPN22 and CTLA-4, genes regarded as genetic master switches of autoimmunity. This raises the issue of the etiology of AAU and the possibility that it should be regarded as an autoinflammatory rather than an autoimmune condition.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 490 495 <span type="species:ncbi:9606">human</span>
###xml 557 565 <span type="species:ncbi:9606">patients</span>
###xml 694 702 <span type="species:ncbi:9606">patients</span>
Uveitis or inflammation of the uvea is a significant cause of visual loss. Clinically, uveitis can be categorized into distinct phenotypes. Acute anterior uveitis (AAU), which presents unilaterally with sudden onset, is self-limiting and recurrent and represents the specific uveitis phenotype associated with ankylosing spondylitis (AS) and other seronegative spondyloarthropathies (SpA) [1]. A link between AAU, AS, and SpA is the major histocompatability complex (MHC) class I molecule, human leucocyte antigen B-27 (HLA-B*27). Although the frequency of patients with AAU who are positive for HLA-B*27 varies among different published surveys, it is generally estimated that among Caucasian patients with AAU, 50% are positive for HLA-B*27 [2].
###end p 11
###begin p 12
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 393 401 <span type="species:ncbi:9606">patients</span>
It is clear that even in HLA-B27-associated AAU, other genetic factors are involved. Several functional polymorphisms in genes that produce proteins relevant to the immune response have been described to either confer an altered susceptibility to autoimmune diseases or appear to influence their severity and outcome. Identification of such polymorphisms is important as it may help to advise patients on prognosis and influence the choice and dose of immunosuppressive drugs, particularly biological agents [3,4].
###end p 12
###begin p 13
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 965 966 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1249 1250 1249 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1251 1252 1251 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 205 210 <span type="species:ncbi:9606">human</span>
A functional single nucleotide polymorphism (SNP) of the gene encoding protein tyrosine phosphatase type 22 (PTPN22; R620W , 1858C/T) has recently been described as a strong common genetic risk factor for human autoimmune disease [5]. PTPN22 is located on chromosome 1p13.3 and encodes a lymphoid-specific phosphatase (Lyp) that binds to c-src tyrosine kinase (Csk), an intracellular tyrosine kinase. Csk phosphorylates leucocyte-specific tyrosine kinase (Lck), leading to the inhibition of Lck kinase activity. The PTPN22 R620W mutation leads to reduced binding of Lyp to Csk, resulting in reduced Lck inactivation, with the overall effect of a gain of function mutation. This is associated with downregulation of early T cell receptor signaling that results in an increase in autoreactive T cells and autoantibody production, a process thought to be due to defective deletion of autoreactive T cells during thymic maturation or dysfunction of regulatory T cells [6]. PTPN22 R620W has been associated with rheumatoid arthritis, type 1 diabetes mellitus, systemic lupus erythematosus, and autoimmune thyroiditis. In contrast, PTPN22 R620W has not been associated with two other presumed autoimmune disorders, multiple sclerosis and Crohn's disease [7,8].
###end p 13
###begin p 14
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 580 586 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 721 727 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 741 747 741 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 641 649 <span type="species:ncbi:9606">patients</span>
###xml 810 818 <span type="species:ncbi:9606">patients</span>
Human Cytotoxic T lymphocyte antigen-4 (CTLA-4) is located on chromosome 2p33, and two well studied polymorphisms in this gene are -318 C to T, () and -49 A to G (). In particular, the 49G polymorphism has been linked to reduced expression of CTLA-4 on the T cell surface, reduced soluble CTLA-4 production, and subsequently impaired inhibitory function [9]. The biological importance of such a change is supported by the findings that the 49 A/G SNP has been associated with Graves' disease, type 1 diabetes mellitus, primary biliary cirrhosis, and, in combination with a second CTLA-4 SNP 6230 G/A, an increased rate of acute rejection in patients undergoing liver transplantation [10-12]. In this study, PTPN22 R620W, CTLA-4 -318C/T, and CTLA-4 49A/G were tested for association with disease in a cohort of patients with AAU. Associations with race, gender, and presence of AS were also tested.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Subjects
###end title 16
###begin p 17
###xml 961 966 <span type="species:ncbi:9606">human</span>
One hundred and forty subjects with AAU were recruited through Oregon Health and Science University, Portland, OR. The diagnostic validation of AAU was based on an ophthalmology chart review by J.R.S. The clinical criteria for the diagnosis of AAU include documented evidence through an assessment by slit-lamp biomicroscopic examination of anterior chamber inflammation that is sudden in onset, unilateral, and resolves within 12 weeks. This form of uveitis is typically episodic, and although it presents unilaterally, it may flip-flop, involving the companion eye in recurrence. Individuals were considered to be affected with uveitis if (1) they met the AAU criteria after careful review of ophthalmology chart notes or (2) they were referred to the study by a uveitis specialist with first-hand knowledge of the subjects' uveitis presentation. Ninety-two race and gender matched healthy individuals were used as controls. This research was conducted under human subject protocols approved by the OHSU, the St. Thomas' Hospital, London and the Sandwell and West Birmingham National health Service Trust, Birmingham, UK local ethics committees and adhered to the Declaration of Helsinki agreement.
###end p 17
###begin title 18
Single nucleotide polymorphism analysis
###end title 18
###begin p 19
###xml 179 185 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 193 199 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 213 219 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 330 337 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
After informed consent, blood samples were collected by venepuncture. Genomic DNA was prepared using standard salt extraction techniques and stored at -70 degreesC until use. The PTPN22 R620W, CTLA-4 -318C/T, and CTLA-4 +49A/G SNPs were detected by sequence-specific primer-polymerase chain reaction (SSP-PCR) using primer mixes (Table 1).
###end p 19
###begin title 20
PCR primer sequences and length of amplification product.
###end title 20
###begin title 21
Statistics
###end title 21
###begin p 22
###xml 69 70 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Associations with disease were sought between allele frequencies. chi2 analysis was performed using EpiStat (EpiStat Group Inc, Atlanta GA). A case-control analysis was employed using the Fisher's exact test.
###end p 22
###begin title 23
Results
###end title 23
###begin p 24
The AAU cohort consisted of 140 subjects (78 female, 62 male) with 133 identified Caucasian by self-report. Of the 140 with AAU, 76 were without history of AS while 58 had a diagnosis and the remaining six subjects were considered to have probable or early signs of AS. The healthy control cohort represented 92 subjects (54 female, 38 male), 81 of whom were Caucasian.
###end p 24
###begin p 25
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 306 313 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 557 564 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
The minor allele frequencies of CTLA-4 -318 and +49 were 8.9% and 42.1%, respectively, in the AAU group, and 4.9% and 36.4%, respectively, in the healthy controls. Although we noted slightly higher minor allele frequencies of both SNPs in the AAU group, the differences were not statistically significant (Table 2). The SNP allele frequencies in the control group were in agreement with other published Caucasian cohorts [9]. Furthermore, sub-analyses with only the Caucasian samples or only the subjects without AS or a haplotype analysis of the two SNPs (Table 2) did not reveal any significant differences between the cases and controls.
###end p 25
###begin title 26
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Allele frequency and genotype analysis of CTLA-4 -318 and +49 polymorphisms in patients with AAU and healthy controls.
###end title 26
###begin p 27
###xml 80 88 <span type="species:ncbi:9606">patients</span>
There was no significant differences in haplotype or genotype frequency between patients with AAU and healthy controls. ns=not significant.
###end p 27
###begin p 28
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 304 311 304 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
The PTPN22 R620W variant allele frequency was 9.8% in the healthy control cohort, which was similar to a UK control cohort and other published reports [7,13]. This was higher than the variant allele frequency found in the AAU group (6.5%), but this difference was not statistically significant (p=0.217; Table 3). By restricting the analysis to Caucasian samples, the variant allele frequency was 11.1% and 6.8% in controls and AAU patients, respectively (p=0.151). Furthermore, sub-analysis of only those AAU subjects without AS revealed no difference between controls (9.8%) and cases (9.21%, p=1.000).
###end p 28
###begin title 29
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Allele frequency and genotype analysis of PTPN22 620W polymorphism in patients with AAU and healthy controls.
###end title 29
###begin p 30
###xml 80 88 <span type="species:ncbi:9606">patients</span>
There was no significant differences in haplotype or genotype frequency between patients with AAU and healthy controls. ns=not significant.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 673 679 673 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 684 690 684 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 637 644 <span type="species:ncbi:9606">patient</span>
Acute anterior uveitis (AAU) is the most common form of immune-mediated uveitis and is strongly associated with HLA-B27 and spondyloarthritis. In this study, we sought to determine if polymorphisms in genes encoding genetic master switches, PTPN22 and CTLA-4, contribute to AAU. The results show that neither PTPN22 R620W nor CTLA-4 SNPs (-318, +49) are associated with AAU in this cohort. As the PTPN22 620W frequency varies in different geographical areas, we analyzed only the Caucasians in our cohort and again found no significant association. Finally, there was no association between any of the polymorphisms tested and AS in the patient group. These data show that PTPN22 and CTLA-4 polymorphisms do not influence onset or severity of AAU.
###end p 32
###begin p 33
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
###xml 572 580 <span type="species:ncbi:9606">patients</span>
As stated, AAU has been strongly linked to HLA-B*27 and SpA. In recent studies, uveitis has been described as a first symptom in nearly half of SpA patients [14]. AAU has also been associated with early onset of SpA in HLA-B*27-positive patients [15]. Conversely, patients with an extraocular disease have a greater number of uveitis relapses compared to ocular disease alone. These studies involved patients at tertiary referral centers. By comparison, in a primary care setting, HLA-B*27, AS, or family history of AS did not influence relapses in these patients whereas patients with one relapse were more likely to have a second event [16]. Therefore, HLA-B*27 appears to be involved with more severe AAU.
###end p 33
###begin p 34
###xml 184 203 184 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 205 226 205 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia trachomatis</italic>
###xml 228 238 228 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 244 251 244 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteus</italic>
###xml 326 335 326 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 184 203 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 205 226 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 244 254 <span type="species:ncbi:229037">Proteus sp</span>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
###xml 326 335 <span type="species:ncbi:210">H. pylori</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
AAU has been classified as an autoimmune condition. However, the evidence to support this is lacking. Numerous studies have shown serum antibodies to Gram negative bacteria, including Helicobacter pylori, Chlamydia trachomatis, Salmonella, and Proteus sp, in HLA-B*27-positive and SpA patients. In particular, the response to H. pylori was greater in patients compared to healthy controls, although this may have been biased by the lack of HLA-B*27 in the control group [17]. Neutrophils and monocytes from patients with active AAU have a decreased expression of Toll-like receptor 2 (TLR2), and reduced cytokine production on signaling through TLR4, which suggests a defect in response to a microbial trigger, and a defect in response to pathogens may be involved in AAU [18].
###end p 34
###begin p 35
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 531 534 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFR1</italic>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1070 1075 1070 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL-2</italic>
###xml 1262 1264 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 671 679 <span type="species:ncbi:9606">patients</span>
###xml 715 723 <span type="species:ncbi:9606">patients</span>
###xml 820 828 <span type="species:ncbi:9606">patients</span>
The lack of association between the SNPs of PTPN22 and CTLA-4 and AAU does not support dysfunction in the adaptive immune response. Therefore, the possibility exists that the defect is in the innate immune system and that AAU is autoinflammatory rather than autoimmune. Autoinflammation is described as local factors at sites predisposed to disease, leading to the activation of innate immune cells including macrophages and neutrophils [19]. Recent genetic studies endorse such a scenario. Polymorphisms in tumor necrosis factor (TNF; -308A and -238A), which are associated with increased production of the cytokine, are significantly more frequent in HLA-B*27-positive patients [20]. Similarly, HLA-B*27-positive patients with extraocular disease show an association with SNPs in the TNFRSF1A gene (TNFR1) compared to patients with AAU alone [21]. Interestingly, anti-TNF therapy has been shown to decrease the number of anterior chamber cells rapidly, to speed resolution of disease, and to reduce the rate of relapse on follow-up [22,23]. A SNP in the gene encoding CCL-2 (-2518G), which is associated with significantly higher production of a chemokine involved in monocyte and neutrophil migration, was significantly associated with HLA-B*27-positive AAU [24]. Increased production and response to TNF in response to infection and exacerbated by the presence of HLA-B*27 [25] would lead to endothelial activation and increased chemokine expression in many sites including the eye with the resultant influx of blood leucocytes, the majority of which would not be ocular specific. The self-limiting and relapsing nature of AAU could be explained by these mechanisms
###end p 35
###begin p 36
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
However, other genes are involved in AAU. A recent whole genome SNP analysis comparing patients with AAU and patients with AS identified a region of chromosome 9 that was linked to AAU but not AS unlike most of the other hotspots [26]. The specific genes involved are currently being investigated.
###end p 36
###begin p 37
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
CTLA-4 polymorphisms have been reported in other ocular diseases. Similar to the findings in the current study, -318C/T and 49A/G were not significantly associated with intermediate uveitis or Behcet's disease [13]. Conversely, in Chinese patients with Vogt-Koyanagi-Harada (VKH) syndrome 49G, and a haplotype based on four CTLA-4 SNPs, linked to reduced function, were associated with susceptibility to the syndrome [27]. In patients with Fuch's heterochromic cyclitis CTLA-4 -318T and a microsatellite repeat, linked to increased function, were associated with disease [28]. These differences may be explained by the nature of the disease type, autoimmune (VKH) or infectious (FHC), compared to idiopathic uveitis or possibly due to ethnic differences. These aspects should be investigated in future studies.
###end p 37
###begin p 38
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FOXP3</italic>
###xml 406 412 406 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA-4</italic>
There are caveats in our study. The SNPs tested are not the only ones reported for these genes, and it remains possible that other mutations may influence AAU. Similarly, other genes including NOD2 and FOXP3 are regarded as master switches of autoimmunity, and these genes were not included in this study. In conclusion, the lack of association between SNPs in the genetic master switches of autoimmunity, PTPN22 and CTLA-4, suggests that regardless of the strong linkage with HLA-B*27, AAU should be regarded as an autoinflammatory rather than an autoimmune condition.
###end p 38
###begin title 39
Acknowledgments
###end title 39
###begin p 40
Supported by Research to Prevent Blindness awards to the Casey Eye Institute, and Drs. Martin, Smith and Rosenbaum; and National Institutes of Health R01-EY-013139. The Birmingham Eye Foundation (G.R. Wallace). The authors wish to thank the individuals with uveitis, referring physicians, and the Spondylitis Association of America for their cooperation. We appreciate the expert assistance of Carrie Austin, Trudy Doyle, Kelley Goodwin and Elli Kondeatis in subject enrollment and technical help.
###end p 40
###begin title 41
References
###end title 41
###begin article-title 42
HLA-B27 associated uveitis.
###end article-title 42
###begin article-title 43
Acute anterior uveitis and HLA-B27.
###end article-title 43
###begin article-title 44
CTLA4 gene polymorphism and autoimmunity.
###end article-title 44
###begin article-title 45
Paths to understanding the genetic basis of autoimmune disease.
###end article-title 45
###begin article-title 46
A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes.
###end article-title 46
###begin article-title 47
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant.
###end article-title 47
###begin article-title 48
PTPN22: setting thresholds for autoimmunity.
###end article-title 48
###begin article-title 49
Role of PTPN22 in type 1 diabetes and other autoimmune disease.
###end article-title 49
###begin article-title 50
CTLA-4 gene polymorphism at position 49 of exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
###end article-title 50
###begin article-title 51
CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and type 1 diabetes mellitus.
###end article-title 51
###begin article-title 52
CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis.
###end article-title 52
###begin article-title 53
Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation.
###end article-title 53
###begin article-title 54
CTLA-4 polymorphisms are not associated with ocular inflammatory disease.
###end article-title 54
###begin article-title 55
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Uveitis as the initial clinical manifestation in patients with spondyloarthropathies.
###end article-title 55
###begin article-title 56
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Characterization and outcome of uveitis in 350 patients with spondyloarthropathies.
###end article-title 56
###begin article-title 57
###xml 20 28 <span type="species:ncbi:9606">patients</span>
Risks of relapse in patients with acute anterior uveitis.
###end article-title 57
###begin article-title 58
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori; an underestimated factor in acute anterior uveitis and spondyloarthopathies.
###end article-title 58
###begin article-title 59
Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function, but not polymorphisms are associated with acute anterior uveitis.
###end article-title 59
###begin article-title 60
A proposed classification of the immunological diseases
###end article-title 60
###begin article-title 61
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
###end article-title 61
###begin article-title 62
TNF -857T, a genetic risk marker for acute anterior uveitis.
###end article-title 62
###begin article-title 63
###xml 115 120 <span type="species:ncbi:9606">human</span>
Anti-tumour necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leucocyte antigen B27-associated acute anterior uveitis.
###end article-title 63
###begin article-title 64
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with anti-tumor necrosis factor agents infliximab and etanercept.
###end article-title 64
###begin article-title 65
Role of CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B-27 associated uveitis.
###end article-title 65
###begin article-title 66
HLA-B27 in health and disease: a double-edged sword.
###end article-title 66
###begin article-title 67
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease.
###end article-title 67
###begin article-title 68
Association of the CTLA-4 gene with Vogt-Koyangi-Harada syndrome.
###end article-title 68
###begin article-title 69
A suggestive association of Fuch's heterochromic cyclitis with cytotoxic T cell antigen 4 polymorphism.
###end article-title 69

